2012
DOI: 10.1556/oh.2012.29267
|View full text |Cite
|
Sign up to set email alerts
|

The possible options for the prevention of preeclampsia

Abstract: This review summarizes the possible options for the prevention of preeclampsia based on important factors of patomechanism. The effects of antioxidants have been described in numerous clinical researches based on the oxidative hypothesis. Another important factor is the change of nitric oxide activity. Nitric oxide donors are able to compensate the symptoms of preeclampsia. The inverse relationship between the calcium intake and gestational hypertension has been known for a long time. The calcium supplementati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 50 publications
0
1
0
1
Order By: Relevance
“…High-risk cases and low-risk cases were divided using Coopland risk factor scoring. Anemia in pregnancy affects not only the health of the mother but also the outcome of the pregnancy and the health of the baby, resulting in an intergenerational cycle of anemia, malnutrition, etc., known public health issues that are more prevalent in developing countries than in developed ones and any other health problems 4,[16][17] .…”
Section: Discussionmentioning
confidence: 99%
“…High-risk cases and low-risk cases were divided using Coopland risk factor scoring. Anemia in pregnancy affects not only the health of the mother but also the outcome of the pregnancy and the health of the baby, resulting in an intergenerational cycle of anemia, malnutrition, etc., known public health issues that are more prevalent in developing countries than in developed ones and any other health problems 4,[16][17] .…”
Section: Discussionmentioning
confidence: 99%
“…A praeeclampsia megelőzésében hatékony lehet a kis molekulatömegű heparinnal és kis dózisú aszpirinnel (LMWH+LDA) végzett kettős thrombosisgátló kezelés [51]. A nagy kockázatú csoportba tartozó nők körében (megelőző súlyos, korai praeeclampsia, kis születési súlyú újszü-lött) kutatást végeztek, és az említett kettős kezelésben részesülők csoportjában az ismétlődő praeeclampsia kialakulása 3% volt, szemben a kizárólag kis dózisú aszpirinnel kezelt csoporttal, ahol 30%-os ismétlődési gyakoriságot tapasztaltak [52].…”
Section: A Haemostasis Változásaiunclassified